Post-Conference Perspectives

Reimbursement With Treatment for Multiple Myeloma
January 03, 2019 – 
Rafael Fonseca, MD, discusses the reimbursement status of the various treatment options for multiple myeloma.
Studies Presented at ASH 2018 and the Outlook for Myeloma
January 03, 2019 – 
Rafael Fonseca, MD, reviews the studies presented at ASH 2018—ARROW, OPTIMISMM, and ELOQUENT-3—and shares the outlook of therapy and unmet needs in myeloma.
MRD Testing and Relapsed/Refractory Multiple Myeloma Treatment Options
December 26, 2018 – 
Rafael Fonseca, MD, defines the clinical significance of minimal residual disease (MRD) testing and the approach to relapsed/refractory for myeloma.
Transplant Patients' Options, CoMMpass Study, and Doublet Versus Triplet Therapy
December 26, 2018 – 
Rafael Foseca, MD, reviews the NCCN guidelines for multiple myeloma and the transplant candidates VRD and KRD and discusses the CoMMpass trial.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.